Delivery Order SPE2DB24D1034-SPE2DB24FVYQ7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,200.93 worth of Tresiba FlexTouch 200 unit/mL 3mL insulin products. The order has an ultimate completion date of April 8, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- This is a $23,508.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,362,864 units of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, with a performance period through August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $2,699.85 order is for the supply of Tresiba FlexTouch, a prescription insulin medication, to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
- This is a $1,601.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,925,708 units of Tresiba FlexTouch 200 Unit/ML 3ML insulin medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical supplies...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a for-profit global pharmaceutical distribution company. The $4,669.14 contract provides TRESIBA FLEXTOUCH 100 UNIT/ML 3ML insulin delivery devices. The award is not a set-aside contract. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,491.38, is for the provision of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $3,735.90 firm fixed price contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a brand name pharmaceutical product, with a period of performance through March 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,334.04 firm fixed price delivery order contract to AmerisourceBergen Drug Corp to supply Tresiba FlexTouch 100 Unit/mL 3mL insulin products. This delivery order is under a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999, which enables the government to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. The award does not have a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,805.10, is for the delivery of Tresiba FlexTouch 200 unit/ml 3ml insulin medication. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $4,152.60 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/ML in 3ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB24FVYQ7Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,001.06 firm fixed price contract is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL, a brand name insulin product, with a period of performance through March 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order is issued under that IDC. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/20/24 |